🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Raj S. Pruthi

University of North Carolina at Chapel Hill

ORCID: 0000-0002-4376-2019

Also affiliated with Engeneic (Australia), Klogene (United States), Engene (Brazil)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database—UNC GOLD

UNC Libraries(2020)10.17615/wp7f-0437
Top 100%
0DataRank
Top 100%0 citations

Matthew E. Nielsen, Raj S. Pruthi, Eric Wallen, Chaochen You, Sarah Gallagher +13 more

Papers

Driven by 20 papers — median percentile 0. Top paper: “Dedicated Residency Research Time and Its Relationship to Urologic Career Academic Success”.

Dedicated Residency Research Time and Its Relationship to Urologic Career Academic Success

Urology(2020)10.1016/j.urology.2020.10.037
N/A
0DataRank · unranked
9 citations

Nikan K. Namiri, Natalie Ríos, Anthony Enriquez, Lindsay A. Hampson, Raj S. Pruthi +2 more

Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients

Urologic Oncology Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.06.030
N/A
0DataRank · unranked
12 citations

Cleo A. Samuel, Sean McCabe, Allison M. Deal, Mattias Jönsson, Dana Mueller +12 more

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

UNC Libraries(2020)10.17615/cymd-0835
N/A
0DataRank · unranked
12 citations

S. Chen, W. Kimryn Rathmell, Caroline Mitchell, I. Espinosa, Lekisha Edwards +8 more

Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy

Urology(2020)10.1016/j.urology.2020.11.036
N/A
0DataRank · unranked
11 citations

Lauren Law, Kyle B. Zuniga, Tracy Kuo Lin, Candy Tsourounis, Rosa Rodríguez-Monguió +10 more

Gender Differences in Compensation, Job Satisfaction and Other Practice Patterns in Urology

UNC Libraries(2020)10.17615/pwfn-tq98
N/A
0DataRank · unranked
1 citations

E. Will Kirby, Chris M. Gonzalez, Joshua P. Langston, Michael E. Woods, Allison M. Deal +9 more

Health Behavior Changes in White and African American Prostate Cancer Survivors

UNC Libraries(2020)10.17615/smn3-h165
N/A
0DataRank · unranked
0 citations

Raj S. Pruthi, Joan F. Walsh, Jessie A. Satia

Resident involvement and experience do not affect perioperative complications following robotic prostatectomy

UNC Libraries(2020)10.17615/jkap-2237
N/A
0DataRank · unranked
0 citations

Eric Wallen, Daniel T. McMillan, Jonathan C. F. Matthews, Angela Smith, Mathew Raynor +4 more

Trends in Stage-Specific Incidence Rates for Urothelial Carcinoma of the Bladder in the United States: 1988 to 2006

UNC Libraries(2020)10.17615/kc17-xf64
N/A
0DataRank · unranked
0 citations

Matthew I. Milowsky, Angela B. Smith, William Y. Kim, Seth Tyree, Tzy Mey Kuo +4 more

Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings

UNC Libraries(2020)10.17615/1nhx-4121
N/A
0DataRank · unranked
0 citations

Tracy L. Rose, Ronald C. Chen, Eric Wallen, Matthew E. Nielsen, Michael E. Woods +11 more

Meta-analysis of Clear Cell Renal Cell Carcinoma Gene Expression Defines a Variant Subgroup and Identifies Gender Influences on Tumor Biology

UNC Libraries(2020)10.17615/sbfe-g063
N/A
0DataRank · unranked
0 citations

W. Kimryn Rathmell, Kathryn E. Hacker, A. Rose Brannon, Matthew E. Nielsen, Eric Wallen +2 more

Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database—UNC GOLD

UNC Libraries(2020)10.17615/wp7f-0437
Top 100%
0DataRank
Top 100%0 citations

Matthew E. Nielsen, Raj S. Pruthi, Eric Wallen, Chaochen You, Sarah Gallagher +13 more

Nutritional predictors of complications following radical cystectomy

UNC Libraries(2020)10.17615/sp72-9r37
N/A
0DataRank · unranked
0 citations

Matthew E. Nielsen, Raj S. Pruthi, Stephen B. Riggs, Jonathan Matthews, Michael E. Woods +3 more

A simple algorithm to assess patient suitability for Calypso-seed implantation for four-dimensional prostate localization

UNC Libraries(2020)10.17615/afet-6f79
Top 100%
0DataRank
Top 100%0 citations

Lawrence B. Marks, Randall J. Kimple, Raj S. Pruthi, Eric Wallen

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4175
N/A
0DataRank · unranked
156 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Phase II trial of escalating doses of neoadjuvant atezolizumab for patients with non-metastatic urothelial carcinoma ineligible for cisplatin-based neoadjuvant chemotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.442
N/A
0DataRank · unranked
8 citations

Divya Natesan, Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng +6 more

Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16510
N/A
0DataRank · unranked
5 citations

Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng, Raj S. Pruthi +15 more

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

European Urology Oncology(2022)10.1016/j.euo.2021.11.005
N/A
0DataRank · unranked
87 citations

Kai Trepka, Martin Sjöström, Emily A. Egusa, Carissa Chu, Jun Zhu +14 more

Feasibility and Delivery of Patient-Reported Outcomes in Clinical Practice Among Racially Diverse Bladder and Prostate Cancer Patients

UNC Libraries(2022)10.17615/nbbr-td17
N/A
0DataRank · unranked
0 citations

Hung‐Jui Tan, Angela Smith, Zahra Mahbooba, Ronald C. Chen, Antonia V. Bennett +12 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730
N/A
0DataRank · unranked
0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730.v1
N/A
0DataRank · unranked
0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more